How do genetic variants impact DMD treatment and prognosis?
The type of genetic variant a person with DMD has can impact which therapies they are eligible for.
The type of genetic variant a person with DMD has can impact which therapies they are eligible for.
The DMD gene is the largest known gene, making it more prone to mutations.
Mdx mice have a mutation in the gene that codes for the protein dystrophin, which is mutated in patients with DMD.
A recent study identified many severe comorbidities in patients with DMD, including gastrointestinal, cardiovascular and kidney conditions.
A recent study found that individuals with DMD who receive eteplirsen have slower declines in cardiac function than those who do not.
World Duchenne Awareness Day takes place on September 7 each year to raise awareness of DMD and advocate for improved research and education.
An open-label extension of the EPIDYS clinical trial found that givinostat is safe and delays disease progression in patients with DMD.
A young man with DMD received a heart transplant at 18 years old and reports positive outcomes after 3.5 years.
A recent study found that inhibiting ADAMTS-5, a cartilage-degrading enzyme, with GLPG1972 supports muscle function in a mouse model of DMD.
Following two fatal cases of acute liver failure associated with ELEVIDYS, Sarepta is taking steps to improve the safety of the drug.